Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8596 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8545 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8352 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8304 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8304 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8304 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8246 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8212 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8208 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8155 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8136 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8136 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8095 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8086 |
Intermediate Similarity |
NPD6190 |
Approved |
0.8081 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8057 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8046 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8036 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8023 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8012 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7978 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7966 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7953 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7921 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7882 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7882 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7861 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7849 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7836 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7826 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7824 |
Intermediate Similarity |
NPD37 |
Approved |
0.7816 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7809 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7809 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7802 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7797 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7797 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7791 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7791 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7791 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7753 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7725 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7719 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7714 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7684 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7665 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7644 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7633 |
Intermediate Similarity |
NPD5403 |
Approved |
0.763 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7602 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7578 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7558 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7556 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD3226 |
Approved |
0.753 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7528 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD919 |
Approved |
0.7485 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7453 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7442 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7432 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7412 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7412 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7381 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7374 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7318 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7317 |
Intermediate Similarity |
NPD447 |
Suspended |
0.731 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7256 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7256 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7246 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7246 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7245 |
Intermediate Similarity |
NPD4002 |
Approved |
0.7245 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7236 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7231 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7231 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7231 |
Intermediate Similarity |
NPD3450 |
Approved |
0.7231 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7213 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7211 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7211 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7208 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7208 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7202 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7202 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7202 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7186 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7176 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7176 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7176 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7157 |
Intermediate Similarity |
NPD7680 |
Approved |
0.715 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7121 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7121 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7121 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7121 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7071 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7059 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7055 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD943 |
Approved |
0.7041 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7035 |
Intermediate Similarity |
NPD2309 |
Approved |
0.703 |
Intermediate Similarity |
NPD3268 |
Approved |
0.703 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7026 |
Intermediate Similarity |
NPD2974 |
Approved |
0.7026 |
Intermediate Similarity |
NPD2975 |
Approved |
0.7026 |
Intermediate Similarity |
NPD2973 |
Approved |
0.7024 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7019 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7015 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7006 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7005 |
Intermediate Similarity |
NPD4580 |
Approved |
0.7 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD7801 |
Approved |
0.6988 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD17 |
Approved |
0.6979 |
Remote Similarity |
NPD4287 |
Approved |
0.6977 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD7038 |
Approved |
0.6968 |
Remote Similarity |
NPD7039 |
Approved |
0.6966 |
Remote Similarity |
NPD6386 |
Approved |
0.6966 |
Remote Similarity |
NPD6385 |
Approved |
0.6954 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6946 |
Remote Similarity |
NPD1240 |
Approved |
0.6941 |
Remote Similarity |
NPD2438 |
Suspended |
0.6938 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD1203 |
Approved |
0.6932
|
Remote Similarity |
NPD920 |
Approved |